Antibiotic Releasing Biodegradable Scaffolds for Osteomyelitis

ISSN: 1875-5704 (Online)
ISSN: 1567-2018 (Print)

Volume 11, 6 Issues, 2014

Download PDF Flyer

Current Drug Delivery

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 126th of 254 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

Istvan Toth
School of Pharmacy,University of Queensland
Brisbane, 4072

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.248

Antibiotic Releasing Biodegradable Scaffolds for Osteomyelitis

Author(s): Manitha Nair and Amit Krishnan

Affiliation: Amrita Vishwa Vidyapeetham University, Cochin, Kerala 682041, India


Osteomyelitis is characterized by progressive inflammatory bone degeneration. In the management of chronic osteomyelitis, it is necessary to remove the infected bone tissue followed by implantation of an antibiotic releasing biomaterial that can release antibiotic locally for long periods of time. The main carrier used in clinics for this application is polymethylmethacrylate (PMMA) (Eg. Septopal beads). However, major drawback is the need of an additional surgery to remove the beads after therapy, as PMMA is not biodegradable. This necessitates the requirement of biodegradable carrier systems that can release antibiotics and simultaneously support debrided bone formation. This review summarizes biodegradable carrier systems that have been reported for the localised treatment and prophylaxis of osteomyelitis

Keywords: Bacterial internalization, Biodegradable scaffolds, Osteomyelitis, Staphylococcus aureus

Purchase Online Order Reprints Order Eprints Rights and Permissions


Article Details

Volume: 11
First Page: 1
Last Page: 14
Page Count: 14
DOI: 10.2174/1567201811666140414120002

Related Journals

Webmaster Contact: Copyright © 2014 Bentham Science